1. Home
  2. NUVB vs FVRR Comparison

NUVB vs FVRR Comparison

Compare NUVB & FVRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVB
  • FVRR
  • Stock Information
  • Founded
  • NUVB 2018
  • FVRR 2010
  • Country
  • NUVB United States
  • FVRR Israel
  • Employees
  • NUVB N/A
  • FVRR 762
  • Industry
  • NUVB Biotechnology: Pharmaceutical Preparations
  • FVRR Business Services
  • Sector
  • NUVB Health Care
  • FVRR Consumer Discretionary
  • Exchange
  • NUVB Nasdaq
  • FVRR Nasdaq
  • Market Cap
  • NUVB 1.1B
  • FVRR 857.6M
  • IPO Year
  • NUVB N/A
  • FVRR 2019
  • Fundamental
  • Price
  • NUVB $3.28
  • FVRR $24.37
  • Analyst Decision
  • NUVB Strong Buy
  • FVRR Buy
  • Analyst Count
  • NUVB 6
  • FVRR 11
  • Target Price
  • NUVB $8.17
  • FVRR $33.10
  • AVG Volume (30 Days)
  • NUVB 6.7M
  • FVRR 603.3K
  • Earning Date
  • NUVB 11-05-2025
  • FVRR 10-29-2025
  • Dividend Yield
  • NUVB N/A
  • FVRR N/A
  • EPS Growth
  • NUVB N/A
  • FVRR 70.84
  • EPS
  • NUVB N/A
  • FVRR 0.50
  • Revenue
  • NUVB $14,355,000.00
  • FVRR $419,126,000.00
  • Revenue This Year
  • NUVB $332.80
  • FVRR $13.15
  • Revenue Next Year
  • NUVB $360.12
  • FVRR $8.00
  • P/E Ratio
  • NUVB N/A
  • FVRR $46.81
  • Revenue Growth
  • NUVB 900.35
  • FVRR 12.60
  • 52 Week Low
  • NUVB $1.54
  • FVRR $20.83
  • 52 Week High
  • NUVB $4.09
  • FVRR $36.11
  • Technical
  • Relative Strength Index (RSI)
  • NUVB 58.18
  • FVRR 56.16
  • Support Level
  • NUVB $3.20
  • FVRR $22.10
  • Resistance Level
  • NUVB $3.41
  • FVRR $24.40
  • Average True Range (ATR)
  • NUVB 0.27
  • FVRR 0.84
  • MACD
  • NUVB -0.03
  • FVRR 0.12
  • Stochastic Oscillator
  • NUVB 33.55
  • FVRR 89.37

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.

Share on Social Networks: